Anti b-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma
Institute for Clinical and Economic Review (ICER)
Record ID 32018002634
English
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://icer.org/assessment/multiple-myeloma-2021/#timeline
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Multiple Myeloma
- Immunotherapy, Adoptive
- B-Cell Maturation Antigen
- Antibodies, Monoclonal
- Immunoconjugates
- Cost-Benefit Analysis
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.